Article
Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions
28 Sept 2024
Abstract excerpt
Myostatin, a potent negative regulator of skeletal muscle mass, has garnered significant attention as a therapeutic target for muscle dystrophies. Despite extensive research and promising preclinical results, clinical trials targeting myostatin inhibition in muscle dystrophies have failed to yield substantial improvements in muscle function or fitness in patients. This review details the mechanisms behind...
Topics
Join the communities discussing this publication.
